[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Sisli Hamidiye Etfal Training and Research Hospital\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":286},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,10,0,[8,45,75,99,135,162,183,200,226,256],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":29,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":4},"100641152","the-effect-of-the-distance-of-the-percutaneous-endoscopic-gastrostomy-peg-feeding-tube-to-the-pylorus-on-the-postoperative-outcomes-100641152",false,"NCT07658079","The Effect of the Distance of the Percutaneous Endoscopic Gastrostomy (PEG) Feeding Tube to the Pylorus on the Postoperative Outcomes","PEG","Inclusion Criteria:\n\n* Over 18 years of age\n* No history of major abdominal surgery (appendectomy, hernia, etc.)\n* Patients who started feeding 24 hours after the PEG procedure\n* Patients not using prokinetic agents.\n\nExclusion Criteria:\n\n* History of stomach, small intestine, large intestine surgery or any history of major abdominal surgery\n* Having undergone surgical gastrostomy\n* Expected gastroparesis (hemodynamic instability, inotropic support, electrolyte imbalance, etc.)\n* Intestinal motility disorder\n* Patients who started feeding early","ALL","18 Years",{"count":19,"type":20},200,"ESTIMATED","7 Days","OBSERVATIONAL","Nutrition is the intake of essential nutrients in sufficient quantities and at the appropriate times to maintain and improve health and enhance quality of life.\n\nEnteral nutrition is superior to parenteral nutrition and should be preferred. To protect the gastrointestinal mucosa and maintain normal flora, patients should begin enteral nutrition as soon as possible. In patients who cannot take food orally, enteral nutrition is provided via a nasogastric\u002Fnasojejunal tube or gastrostomy tube.\n\nGastrostomy is the first choice for patients with a functional gastrointestinal system, poor oral intake, and requiring long-term nutritional support. Feeding tubes can be placed percutaneously or surgically. Percutaneous endoscopic gastrostomy (PEG) is a minimally invasive procedure that does not increase morbidity or mortality, is cheaper, and saves time compared to surgical gastrostomy. It was first applied in 1980 as an alternative to surgical gastrostomy. During the procedure, a line was defined between the navel and the middle of the left lower costal margin. A feeding tube was then inserted at the junction of the middle 2\u002F3 and the outer 1\u002F3 under local anesthesia, and feeding was started the following day. Vudayagiri et al. reported that the placement site is generally 2 cm medial to the costal margin and 2 cm below the xiphoid process.\n\nDifferent methods for placing a PEG tube into the stomach (pull technique, push technique, and Russell method) have been described in the literature, with the most common being the \"pull\" technique. The 2005 ESPEN guidelines noted that in the \"pull\" technique, gastroscopic visualization of the anterior gastric wall is performed, followed by determination of the puncture site at the distal corpus level.\n\nThe exact location of the PEG feeding tube, both on the skin and within the gastric lumen, is not fully understood. Its localization on the abdominal skin will be optimally achieved through endoscopic transillumination. However, its level within the gastric lumen is predictable. In our study, we aimed to investigate how measuring the distance of the feeding tube from the pylorus in patients undergoing PEG placement affects post-procedure outcomes and to determine the optimal level within the gastric lumen. Additionally, the placement of the catheter on the skin will be recorded in each patient. Traditionally, tube feeding has been delayed until up to 24 hours after percutaneous endoscopic gastrostomy (PEG) procedure. However, results from various randomized controlled trials suggest that early feeding may be an option. A meta-analysis indicated that early feeding (\\\u003C or = 4 hours) after PEG placement may be a safe alternative to delayed or next-day feeding. However, although there was no difference in overall complications in this meta-analysis, there was a significant increase in gastric residual volume on day 1 in patients who started early feeding. In another meta-analysis conducted by Szary et al., early tube feeding ≤3 hours after PEG placement; Complications, death within ≤72 hours, or significant gastric residual volume on day 1 were found to be significantly different from delayed or next-day feeding. Our study will be the first of its kind in this field. Therefore, to minimize all factors that could negatively affect the results, we will initiate enteral feeding 24 hours after the traditionally used procedure.",[25,26,27,28],"Poor Oral Intake","Requiring Long-term Nutritional Support","Percutaneous Endoscopic Gastrostomy","Nutrition Disorders",[30,31,32],"Percutaneous Endoscopic Gastrostomy (PEG)","Pylorus","Postoperative Outcomes","NOT_YET_RECRUITING","2026-06-14",{"date":36,"type":37},"2026-06-18","ACTUAL",{"date":39,"type":20},"2026-06-01",{"date":41,"type":20},"2027-08-31",{"name":43,"class":44},"Sisli Hamidiye Etfal Training and Research Hospital","OTHER",{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":52,"targetDuration":4,"studyType":54,"phases":55,"briefSummary":57,"conditions":58,"keywords":62,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":70,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},"100638697","ultrasound-guided-rectus-sheath-block-versus-local-infiltration-100638697","NCT07582029","Ultrasound-Guided Rectus Sheath Block Versus Local Infiltration","Comparison of the Analgesic Effects of Local Anesthetic Infiltration and Ultrasound-Guided Rectus Sheath Block in Laparoscopic Cholecystectomy Operations: A Prospective Randomized Controlled Study","Inclusion Criteria:\n\n* ASA (American Society of Anesthesiologists) class I-II patients\n* Patients aged between 18 and 65 years\n* Patients undergoing laparoscopic cholecystectomy surgery\n\nExclusion Criteria:\n\n* ASA class III-IV patients\n* Patients undergoing emergency surgery\n* Relatives of patients who do not provide consent\n* Presence of chronic pain\n* Chronic opioid use\n* Presence of local anesthetic allergy\n* Ibuprofen allergy\n* Paracetamol allergy\n* Presence of infection at the block site\n* Coagulopathy\n* Increased intracranial pressure\n* Pre-existing neurological deficit\n* Severe organ failure\n* Mental retardation\n* Anatomical deformity",{"count":53,"type":20},60,"INTERVENTIONAL",[56],"NA","Laparoscopic cholecystectomy is associated with significant postoperative pain originating from trocar sites, pneumoperitoneum, and visceral irritation. Both local anesthetic infiltration and ultrasound-guided rectus sheath block are commonly used regional analgesic techniques to reduce postoperative pain and opioid consumption. This prospective randomized controlled study aims to compare the effects of these two techniques on postoperative pain scores, opioid requirements, and analgesia-related adverse effects following laparoscopic cholecystectomy.",[59,60,61],"Cholelithiases","Cholecystitis","Postoperative Pain",[63,64,65,66],"Cholecystectomy, Laparoscopic","Rectus Sheath Block","Anesthesia, Local","Pain, Postoperative","2026-05-06",{"date":69,"type":37},"2026-05-12",{"date":69,"type":20},{"date":72,"type":20},"2026-12-12",{"name":43,"class":44},1,{"id":76,"slug":77,"hasResults":11,"nctId":78,"briefTitle":79,"officialTitle":80,"acronym":4,"eligibilityCriteria":81,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":82,"enrollmentInfo":83,"targetDuration":4,"studyType":54,"phases":85,"briefSummary":86,"conditions":87,"keywords":90,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":4},"100618621","the-effects-of-conventional-therapy-on-tinnitus-disability-and-quality-of-life-in-patients-with-tinnitus-100618621","NCT07334002","The Effects of Conventional Therapy on Tinnitus, Disability, and Quality of Life in Patients With Tinnitus","A Randomized, Single-blind, Controlled Trial to Evaluate the Effects of Conventional Therapy on Tinnitus, Disability, and Quality of Life in Patients With Tinnitus","Inclusion Criteria:\n\n* Patients with a type A tympanogram in the tympanogram of all cases with normal otological examinations (air-bone gap should not be observed in any case).\n\nExclusion Criteria:\n\n* Patients with a disease that may cause objective tinnitus,\n\n  * Otosclerosis,\n  * Chronic otitis media,\n  * Acoustic tumor,\n  * Meniere's disease,\n  * History of ear surgery or head trauma, and those with neuropsychiatric diseases.\n\nAlso:\n\n* Patients who have had ear surgery,\n* Permanent hearing loss (total),\n* Severe cardiovascular system failure, uncontrolled arrhythmia,\n* Severe renal failure, or liver failure","70 Years",{"count":84,"type":20},30,[56],"A randomized, single-blind, controlled trial to evaluate the effects of neural therapy on tinnitus severity, disability, and quality of life in patients with tinnitus.\n\nThe study is planned to be conducted between December 2025 and March 2026. The sample size is 30 patients. The number of centers is 1. The study duration is 3 months.",[88,89],"Tinnitus","Neural Therapy of Huneke",[89,88],"2026-03-20",{"date":93,"type":37},"2026-03-23",{"date":95,"type":20},"2026-03-01",{"date":97,"type":20},"2026-05-26",{"name":43,"class":44},{"id":100,"slug":101,"hasResults":11,"nctId":102,"briefTitle":103,"officialTitle":104,"acronym":105,"eligibilityCriteria":106,"healthyVolunteers":11,"sex":16,"minAge":107,"maxAge":108,"enrollmentInfo":109,"targetDuration":4,"studyType":54,"phases":111,"briefSummary":112,"conditions":113,"keywords":115,"overallStatus":126,"whyStopped":4,"lastUpdateSubmitDate":127,"lastUpdatePostDateStruct":128,"startDateStruct":130,"completionDateStruct":132,"leadSponsor":134,"locationsCount":74},"100629593","effect-of-reswt-session-frequency-on-spasticity-and-function-assessed-by-sonoelastography-in-children-with-cerebral-palsy-100629593","NCT07476690","Effect of rESWT Session Frequency on Spasticity and Function Assessed by Sonoelastography in Children With Cerebral Palsy","The Effect of Radial Extracorporeal Shock Wave Therapy (rESWT) Session Frequency on Spasticity, Function, Balance, and Muscle Morphology in Children With Cerebral Palsy: A Randomized Controlled Trial Using Sonoelastography","CP-rESWT-FREQ","Inclusion Criteria:\n\n* Children aged 6-14 years diagnosed with cerebral palsy according to the Rosenbaum diagnostic criteria.\n* Gross Motor Function Classification System (GMFCS) level I, II, or III.\n* Modified Ashworth Scale (MAS) score \\>1 and ≤3 in unilateral or bilateral ankle plantar flexor muscle groups.\n* Presence of a spastic gait pattern characterized by a dynamic component of ankle equinus.\n\nExclusion Criteria:\n\n* Age younger than 6 years or older than 14 years.\n* Botulinum toxin type A injection or extracorporeal shock wave therapy (ESWT) within 6 months prior to enrollment.\n* Fixed contracture with passive joint range of motion (ROM) \\\u003C5° in the affected extremity, or significant bone or joint deformity.\n* History of orthopedic surgery (tendon release or transfer, tenotomy, muscle release surgery, arthrodesis) involving the affected extremity.\n* Cognitive or behavioral disorders that would prevent participation in the intervention or assessments.\n* Uncontrolled systemic disease or significant comorbid conditions.\n* History of neurosurgical intervention (e.g., selective dorsal rhizotomy, neurectomy).\n* Presence of significant dystonia or severe movement disorder in the extremity to be evaluated.\n* Presence of contraindications for ESWT application in the treatment area, including open skin lesions, skin infection, signs of active inflammation, or history of malignancy; bleeding diathesis, use of anticoagulant therapy, or circulatory problems due to vascular pathology.","6 Years","14 Years",{"count":110,"type":20},45,[56],"Spasticity is a major contributor to functional limitations in children with cerebral palsy. Radial extracorporeal shock wave therapy (rESWT) has emerged as a non-invasive method for reducing spasticity; however, the optimal session frequency remains unclear. This randomized, assessor-blinded, parallel-group controlled trial investigates the effects of different rESWT session frequencies on spasticity, motor function, balance, pain, and muscle properties in children with cerebral palsy.\n\nParticipants are randomly assigned to three groups receiving sham rESWT, one real rESWT session per week combined with sham, or two real rESWT sessions per week, in addition to routine neurological rehabilitation. Outcomes are assessed using clinical scales and ultrasonography-based measures, including shear wave elastography. The study aims to define the dose-response relationship of rESWT and inform optimal treatment protocols in pediatric neurorehabilitation.",[114],"Cerebral Palsy (CP)",[116,117,118,119,120,121,122,123,124,125],"Cerebral Palsy","Extracorporeal Shock Wave Therapy","rESWT","Session Frequency","Spasticity","Muscle Stiffness","Sonoelastography","Physical Function","Balance","Pediatric Rehabilitation","RECRUITING","2026-03-12",{"date":129,"type":37},"2026-03-17",{"date":131,"type":37},"2025-11-15",{"date":133,"type":20},"2026-06-15",{"name":43,"class":44},{"id":136,"slug":137,"hasResults":11,"nctId":138,"briefTitle":139,"officialTitle":140,"acronym":4,"eligibilityCriteria":141,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":142,"targetDuration":144,"studyType":22,"phases":4,"briefSummary":145,"conditions":146,"keywords":149,"overallStatus":126,"whyStopped":4,"lastUpdateSubmitDate":154,"lastUpdatePostDateStruct":155,"startDateStruct":157,"completionDateStruct":159,"leadSponsor":161,"locationsCount":74},"100602637","prospective-validation-of-grady-a-machine-learning-model-for-early-sepsis-and-bacteremia-detection-in-icu-patients-100602637","NCT07126106","Prospective Validation of GRADY: A Machine Learning Model for Early Sepsis and Bacteremia Detection in ICU Patients","Prospective Validation of the GRADY Bacteremia\u002FSepsis Prediction Model in Intensive Care Unit Patients: Clinical Performance and Feasibility as an Early Warning System","Inclusion Criteria:\n\n* Patients aged 18 years or older\n* ICU stay of 48 hours or longer\n* Patients from whom blood cultures were obtained during routine monitoring\n* Signed informed consent form\n\nExclusion Criteria:\n\n* Patients younger than 18 years\n* ICU stay shorter than 48 hours\n* Patients without blood cultures",{"count":143,"type":20},55,"12 Months","This study aims to prospectively validate the GRADY prediction models, which use machine learning algorithms to estimate the risk of gram-negative bacteremia and sepsis in intensive care unit (ICU) patients based on routinely collected vital signs and laboratory data. Sepsis, a life-threatening condition associated with high ICU mortality, requires early diagnosis and treatment-yet current diagnostic methods relying on blood cultures are time-consuming. Existing scoring systems such as SOFA, SIRS, and NEWS2 often lack sufficient sensitivity and specificity in early sepsis detection. Unlike traditional tools, the GRADY models seek to provide earlier and more accurate risk stratification. This study will compare the clinical performance of GRADY models against standard scoring systems and explore their integration as early warning tools to support rapid intervention and improve outcomes in critical care.",[147,148],"Bacteremia","Sepsis Bacterial",[150,151,152,153],"Bloodstream Infection","sepsis","Machine Prediction Methods","external validation","2025-08-15",{"date":156,"type":37},"2025-08-17",{"date":158,"type":37},"2025-02-01",{"date":160,"type":20},"2026-01-01",{"name":43,"class":44},{"id":163,"slug":164,"hasResults":11,"nctId":165,"briefTitle":166,"officialTitle":166,"acronym":4,"eligibilityCriteria":167,"healthyVolunteers":11,"sex":16,"minAge":168,"maxAge":17,"enrollmentInfo":169,"targetDuration":4,"studyType":54,"phases":171,"briefSummary":172,"conditions":173,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":175,"lastUpdatePostDateStruct":176,"startDateStruct":178,"completionDateStruct":180,"leadSponsor":182,"locationsCount":4},"100585391","effectiveness-of-kinesiotaping-in-adolescent-idiopathic-scoliosis-100585391","NCT06901752","Effectiveness of Kinesiotaping in Adolescent Idiopathic Scoliosis","Inclusion Criteria:\n\n* Being under follow-up with the diagnosis of Adolescent Idiopathic Scoliosis\n* Having a Cobb angle between 10-25 degrees\n* Being willing to participate in the study\n* Having thoracic C scoliosis\n\nExclusion Criteria:\n\n* Having a spinal curvature of more than 25 degrees\n* Presence of cardiopulmonary disease and musculoskeletal deformity that will prevent exercise\n* Having an open wound in the area where kinesio taping will be applied or being allergic to the tape application\n* Presence of S scoliosis","10 Years",{"count":170,"type":20},54,[56],"The effectiveness of kinesiotaping application in addition to exercise in Adolescent Idiopathic Scoliosis will be compared on the pain level with the numerical rating scale, the Cobb angle and scoliometer measurements, the quality of life with the Scoliosis Research Association-22 quality of life scale, and the patient's visual perception level with the Walter Reed visual assessment scale. Research Group: In addition to the regular exercise program, kinesio taping will be applied to patients diagnosed with Adolescent Idiopathic Scoliosis. Kinesio taping will be applied for 5 days on and 2 days off for 4 weeks. Control Group: Patients diagnosed with Adolescent Idiopathic Scoliosis will continue their regular exercise program. No intervention will be applied. Patients will be evaluated before and 3 months after treatment in terms of pain level with numerical rating scale, Cobb angle measurement and Scoliometer measurement, quality of life with Scoliosis Research Association-22 quality of life scale and Walter Reed visual assessment scale.",[174],"Scoliosis Idiopathic Adolescent","2025-03-23",{"date":177,"type":37},"2025-03-30",{"date":179,"type":20},"2025-03-28",{"date":181,"type":20},"2025-09-30",{"name":43,"class":44},{"id":184,"slug":185,"hasResults":11,"nctId":186,"briefTitle":187,"officialTitle":187,"acronym":4,"eligibilityCriteria":188,"healthyVolunteers":11,"sex":16,"minAge":189,"maxAge":190,"enrollmentInfo":191,"targetDuration":4,"studyType":54,"phases":192,"briefSummary":193,"conditions":194,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":175,"lastUpdatePostDateStruct":196,"startDateStruct":197,"completionDateStruct":198,"leadSponsor":199,"locationsCount":4},"100585392","effectiveness-of-kinesio-taping-in-patients-with-congenital-muscular-torticollis-100585392","NCT06901765","Effectiveness of Kinesio Taping in Patients with Congenital Muscular Torticollis","Inclusion Criteria:\n\n* Being followed up with a diagnosis of Congenital Muscular Torticollis\n* The family's willingness to participate in the study\n\nExclusion Criteria:\n\n* Presence of cardiopulmonary disease and musculoskeletal deformity that will prevent exercise\n* Having an open wound in the area where kinesio taping will be applied or being allergic to tape application","0 Years","2 Years",{"count":170,"type":20},[56],"The aim is to investigate the effectiveness of kinesiotaping application in addition to Congenital Muscular Torticollis exercise on neck joint range of motion, tilt degree and muscle function test. Research Group: In addition to the regular exercise program, patients diagnosed with Congenital Muscular Torticollis will be given kinesio taping for torticollis. Kinesio taping will be applied for 4 weeks, 5 days on and 2 days off. Control Group: Patients diagnosed with Congenital Muscular Torticollis will continue their regular exercise program. No intervention will be applied. Patients will be evaluated with neck joint range of motion, tilt degree and muscle function test before and 3 months after treatment.",[195],"Torticollis Congenital",{"date":177,"type":37},{"date":179,"type":20},{"date":181,"type":20},{"name":43,"class":44},{"id":201,"slug":202,"hasResults":11,"nctId":203,"briefTitle":204,"officialTitle":205,"acronym":4,"eligibilityCriteria":206,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":207,"enrollmentInfo":208,"targetDuration":4,"studyType":54,"phases":209,"briefSummary":210,"conditions":211,"keywords":214,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":218,"lastUpdatePostDateStruct":219,"startDateStruct":221,"completionDateStruct":223,"leadSponsor":225,"locationsCount":74},"100585052","transversus-abdominis-plan-block-versus-rectus-sheath-block-100585052","NCT06897345","Transversus Abdominis Plan Block Versus Rectus Sheath Block","Comparison of Postoperative Analgesic Efficacy of Transversus Abdominis Plan Block and Rectus Sheath Block in Abdominoplasty Cases: A Randomized Prospective Clinical Trial","Inclusion Criteria:\n\nPatients who will undergo elective abdominoplasty\n\n* Patients between the ages of 18-65\n* ASA (American Society of Anesthesiologists) I-II-III patients\n* Patients with a body weight between 50-80 kg\n\nExclusion Criteria:\n\n* \\- ASA IV patient group\n* Patients under 18 years of age\n* Patients without cooperation\n* Patients with chronic alcohol use\n* Patients in whom peripheral plane block application is contraindicated (infection at the application site, coagulopathy, local anesthetic allergy)\n* Patients who do not want to participate in the study","65 Years",{"count":53,"type":20},[56],"The investigator aims to compare the analgesic efficacy of Transversus Abdominis Plan Block and Rectus Sheath Block which are used to prevent intraoperative and postoperative pain and reduce the use of opioid in abdominoplasty operations.",[212,61,213],"Abdominal Obesity","Postoperative Complications",[215,216,217],"post operative pain","transversus abdominis plane block","rectus sheat block","2025-03-20",{"date":220,"type":37},"2025-03-26",{"date":222,"type":20},"2025-05-01",{"date":224,"type":20},"2025-12-01",{"name":43,"class":44},{"id":227,"slug":228,"hasResults":11,"nctId":229,"briefTitle":230,"officialTitle":231,"acronym":4,"eligibilityCriteria":232,"healthyVolunteers":233,"sex":16,"minAge":207,"maxAge":4,"enrollmentInfo":234,"targetDuration":4,"studyType":54,"phases":236,"briefSummary":237,"conditions":238,"keywords":243,"overallStatus":126,"whyStopped":4,"lastUpdateSubmitDate":248,"lastUpdatePostDateStruct":249,"startDateStruct":251,"completionDateStruct":253,"leadSponsor":255,"locationsCount":74},"100542468","the-effects-of-general-versus-spinal-anesthesia-on-postoperative-myocardial-injury-100542468","NCT06343259","The Effects of General Versus Spinal Anesthesia on Postoperative Myocardial Injury","Comparison of The Effects of General Anesthesia and Spinal Anesthesia on The Development of Postoperative Myocardial Injury in Elderly Patients Undergoing Hip Surgery","Inclusion Criteria:\n\n* who will undergo hip surgery\n* ASAII-III\n* Over the age of 65\n\nExclusion Criteria:\n\n* Patients diagnosed with sepsis, pulmonary embolism, decompensated heart failure, chronic kidney failure.\n* Patients who underwent cardioversion in the last 6 months or experienced myocardial infarction.\n* Patients with a surgical history in the last month.\n* Patients who required intubation in the intensive care unit.\n* Patients with a baseline Hs-Troponin T value exceeding 20 ng\u002FL.\n* Patients with a postoperative peak Hs-Troponin T value higher than baseline.",true,{"count":235,"type":20},100,[56],"In this prospective, randomized, single-blind study, we aim to compare the effects of general anesthesia and spinal anesthesia on postoperative myocardial injury in elderly patients undergoing hip surgery. Cardiovascular events are a leading cause of mortality and morbidity following non-cardiac surgery, with myocardial injury after non-cardiac surgery (MINS) being a significant concern. MINS, characterized by asymptomatic elevation of troponin levels without accompanying ECG findings, is closely associated with postoperative mortality. With the increasing prevalence of comorbidities in the elderly population and the rising frequency of non-cardiac surgeries in this demographic, understanding the effects of different anesthesia types on postoperative myocardial injury is crucial.",[239,240,241,242],"Myocardial Injury After Non-cardiac Surgery","Hypotension During Surgery","Anesthesia, General","Anesthesia, Spinal",[244,241,242,245,246,247],"MINS","Hip Fractures","Myocardial Infarction","Troponin T","2024-07-22",{"date":250,"type":37},"2024-07-23",{"date":252,"type":37},"2024-04-05",{"date":254,"type":20},"2024-08-18",{"name":43,"class":44},{"id":257,"slug":258,"hasResults":11,"nctId":259,"briefTitle":260,"officialTitle":261,"acronym":4,"eligibilityCriteria":262,"healthyVolunteers":11,"sex":16,"minAge":263,"maxAge":264,"enrollmentInfo":265,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":267,"conditions":268,"keywords":273,"overallStatus":126,"whyStopped":4,"lastUpdateSubmitDate":279,"lastUpdatePostDateStruct":280,"startDateStruct":282,"completionDateStruct":283,"leadSponsor":285,"locationsCount":74},"100551973","frequency-of-adverse-events-in-pediatric-patients-receiving-sedation-for-magnetic-resonance-imaging-100551973","NCT06467045","Frequency of Adverse Events in Pediatric Patients Receiving Sedation for Magnetic Resonance Imaging","Frequency of Adverse Events and Factors Causing Adverse Events in Pediatric Patients Receiving Sedation for Magnetic Resonance Imaging: Observational Study","Inclusion Criteria:\n\n* All non-intubated patients under the age of 16 were included in the study.\n\nExclusion Criteria:\n\n* Intubated pediatric patients or older than 16 years patients were excluded.","0 Days","16 Years",{"count":266,"type":20},500,"Introduction:The application of anesthesia outside the operating room for pediatric patients has increased in recent years. For diagnostic and treatment follow-up purposes, magnetic resonance imaging (MRI) requires the pediatric patient to remain still, necessitating sedation. The study aimed to determine the frequency of adverse effects and influencing factors in pediatric patients undergoing sedation during MRI.\n\nMethods: Between 19.06.2024 and 16.09.2024, estimated 500 pediatric patients who underwent MRI under sedation will be prospectively observed. All non-intubated patients under the age of 16 will be included in the study. The demographic data, comorbidities, and medications of the patients, the procedures performed, the anesthetic drugs used, the expertise duration of the anesthesiologist, and the adverse effects encountered will be recorded.",[269,270,271,272],"Sedation","Pediatric Anesthesia","Magnetic Resonance Imaging","Adverse Effect",[274,275,276,277,278],"pediatric","adverse effects","magnetic resonance imaging","sedation","anesthesia","2024-06-24",{"date":281,"type":37},"2024-06-25",{"date":279,"type":37},{"date":284,"type":20},"2024-10-05",{"name":43,"class":44},""]